AllCells
AllCells
Home » Products » By Disease » Chronic Lymphoid Leukemia (CLL)

Chronic Lymphoid Leukemia (CLL)

Background

Chronic Lymphocytic Leukemia (CLL) also known as B cell chronic lymphocytic leukemia (B-CLL) is a slow growing cancer of the blood that affects older adults.  CLL originates in the bone marrow and then spreads to the blood and lymph nodes.  Characterization by flow cytometry demonstrates that these cells are CD5+  and CD19+.  Prognosis of CLL is dependent on the cytogenic profile of the cancer.  Deletions of part of the short arm of chromosome 17 (del 17p) or deletions of the long arm on chromosome 11 (del 11q) indicate a poorer outcome while deletions of the long arm of chromosome 13 (del 13q) favors a better prognosis.  

AllCells provides bone marrow and peripheral blood samples of newly diagnosed or relapsed/refractory CLL patients.

Spacer Middle

Sign-Up for Our eNewsletter


Bottom Curve
Spacer Middle
News & Events
2012-02-03 | AllCells, WiCell, and WARF Enter into Biomaterials License Agreement
2012-02-01 | AllCells to present at upcoming 7th Annual New York Stem Cell Summit
Spacer Middle

Chronic Lymphoid Leukemia (CLL)

View 10 | 25 | 50 | All
Narrow Your Choices

Species



Tissue Type





Cell Type





Format






  Catalog # Format Name Size Price Qty.
cDNA-CLL-T005 cDNA Frozen CLL PB CD2+ T Cells (Newly Diagnosed / Untreated) cDNA, 10 PCR rxns 10 PCR rxns $550
cDNA-CLL-B008 cDNA Frozen CLL BM CD19+ B Cells (Relapsed / Refractory) cDNA, 10 PCR rxns 10 PCR rxns $550
RNA-CLL-B008C Comprehensive RNA CLL Bone Marrow CD19+ B Cells (Relapsed/Refractory) Comprehensive RNA 3.0 μg $524/vial
cDNA-CLL-B010 cDNA Frozen CLL BM CD19+/CD5+ B Cells (Relapsed / Refractory) cDNA, 10 PCR rxns 10 PCR rxns $641
CLL-B044F Frozen Frozen CLL BM CD19+/CD5+ B Cells (Relapsed / Refractory), 5 million/vial 5 million $1707/vial
CLL-B043F Frozen Frozen CLL BM CD19+/CD5+ B Cells (Relapsed / Refractory), 1 million/vial 1 million $611/vial
$305.5/vial
CLL-B040F Frozen CLL Bone Marrow CD19+/CD5+ B Cells (Untreated) 20 million $4640/vial
$1856/vial
CLL-B039F Frozen CLL Bone Marrow CD19+/CD5+ B Cells (Untreated) 10 million $2790/vial
$1116/vial
CLL-B038F Frozen Frozen CLL BM CD19+/CD5+ B Cells (Newly Diagnosed / Untreated), 5 million/vial 5 million $1707/vial
$853.5/vial
CLL-B037F Frozen Frozen CLL BM CD19+/CD5+ B Cells (Newly Diagnosed / Untreated), 1 million/vial 1 million $611/vial

Top ^